Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Finished Goods (2020 - 2021)

Historic Finished Goods for UroGen Pharma (URGN) over the last 2 years, with Q1 2021 value amounting to $888000.0.

  • UroGen Pharma's Finished Goods changed N/A to $888000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $888000.0, marking a year-over-year change of. This contributed to the annual value of $913000.0 for FY2020, which is N/A changed from last year.
  • Per UroGen Pharma's latest filing, its Finished Goods stood at $888000.0 for Q1 2021.
  • UroGen Pharma's 5-year Finished Goods high stood at $913000.0 for Q4 2020, and its period low was $232000.0 during Q2 2020.